BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9551915)

  • 1. Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule.
    Tallquist MD; Weaver AJ; Pease LR
    J Immunol; 1998 Jan; 160(2):802-9. PubMed ID: 9551915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactive 2C T cells recognize a self peptide in the context of the mutant Kbm3 molecule.
    Tallquist MD; Pease LR
    J Immunol; 1995 Sep; 155(5):2419-26. PubMed ID: 7544375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation.
    Motyka B; Teh HS
    J Immunol; 1998 Jan; 160(1):77-86. PubMed ID: 9551958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity.
    Hornell TM; Myers N; Hansen TH; Connolly JM
    J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor.
    Schlueter CJ; Manning TC; Schodin BA; Kranz DM
    J Immunol; 1996 Nov; 157(10):4478-85. PubMed ID: 8906825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.
    Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P
    J Immunol; 1996 Jul; 157(2):670-8. PubMed ID: 8752916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.
    O'Herrin SM; Lebowitz MS; Bieler JG; al-Ramadi BK; Utz U; Bothwell AL; Schneck JP
    J Exp Med; 1997 Oct; 186(8):1333-45. PubMed ID: 9334373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition.
    Solheim JC; Carreno BM; Smith JD; Gorka J; Myers NB; Wen Z; Martinko JM; Lee DR; Hansen TH
    J Immunol; 1993 Nov; 151(10):5387-97. PubMed ID: 7693810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I-restricted cytotoxic T cell recognition of split peptide ligands.
    Gillanders WE; Hanson HL; Rubocki RJ; Hansen TH; Connolly JM
    Int Immunol; 1997 Jan; 9(1):81-9. PubMed ID: 9043950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR internalization induced by peptide/MHC ligands requires the transmembrane domains of alphabeta chains of TCR, but not the expression of CD8 and Thy-1 molecules.
    Lee MH; Min D; Sonn CH; Lee KN; Kim KE; Paik SG; Kim YS
    Mol Cells; 1999 Dec; 9(6):617-24. PubMed ID: 10672928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity.
    Tallquist MD; Yun TJ; Pease LR
    J Exp Med; 1996 Sep; 184(3):1017-26. PubMed ID: 9064319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.